Sustained Virologic Response [setrvalá virologická odpověď]

topical
19
Terms

Sustained Viral Suppression

Persistent link   https://www.medvik.cz/link/D000072230
Definition

The continuous, long-term suppression of VIRAL LOAD, generally to undetectable levels, as the result of treatment with ANTIVIRAL AGENTS.

DUI
D000072230 MeSH Browser
CUI
M000616660
Previous indexing
Antiviral Agents/therapeutic use (1999-2016); Drug Therapy, Combination (1999-2016); Treatment Outcome (1999-2016)
History note
2017
Public note
2017

E Analytical, Diagnostic and Therapeutic Techniques and Equipment
E01 Diagnosis 1 790
E01.789 Prognosis 9 647
E01.789.800 Treatment Outcome 21 685
E01.789.800.190 Disease-Free Survival 1 443
E01.789.800.238 Early Termination of Clinical Trials 16
E01.789.800.262 Pathologic Complete Response 5
E01.789.800.285 Progression-Free Survival 493
E01.789.800.379 Response Evaluation Criteria in Solid Tumors 42
E01.789.800.570 Sustained Virologic Response 19
E01.789.800.665 Therapeutic Index 6
E01.789.800.713 Treatment Expectations
E01.789.800.760 Treatment Failure 668

N Health Care
N04 Health Services Administration 1 737
N04.761 Quality of Health Care 2 491
N04.761.559 Outcome and Process Assessment, Health Care 1 870
N04.761.559.590 Outcome Assessment, Health Care 584
N04.761.559.590.800 Treatment Outcome 21 685
N04.761.559.590.800.190 Disease-Free Survival 1 443
N04.761.559.590.800.379 Early Termination of Clinical Trials 16
N04.761.559.590.800.427 Pathologic Complete Response 5
N04.761.559.590.800.474 Progression-Free Survival 493
N04.761.559.590.800.569 Response Evaluation Criteria in Solid Tumors 42
N04.761.559.590.800.665 Sustained Virologic Response 19
N04.761.559.590.800.713 Therapeutic Index 6
N04.761.559.590.800.737 Treatment Expectations
N04.761.559.590.800.760 Treatment Failure 668
N05 Health Care Quality, Access, and Evaluation 685
N05.715 Quality of Health Care 2 491
N05.715.360 Health Care Evaluation Mechanisms 200
N05.715.360.575 Outcome and Process Assessment, Health Care 1 870
N05.715.360.575.575 Outcome Assessment, Health Care 584
N05.715.360.575.575.800 Treatment Outcome 21 685
N05.715.360.575.575.800.190 Disease-Free Survival 1 443
N05.715.360.575.575.800.379 Early Termination of Clinical Trials 16
N05.715.360.575.575.800.427 Pathologic Complete Response 5
N05.715.360.575.575.800.474 Progression-Free Survival 493
N05.715.360.575.575.800.569 Response Evaluation Criteria in Solid Tumors 42
N05.715.360.575.575.800.665 Sustained Virologic Response 19
N05.715.360.575.575.800.713 Therapeutic Index 6
N05.715.360.575.575.800.737 Treatment Effect Heterogeneity
N05.715.360.575.575.800.749 Treatment Expectations
N05.715.360.575.575.800.760 Treatment Failure 668

Add